European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Boehringer Ingelheim Auslandsbeteiligungs GmbH, Ingelheim a. Rhein, Germany

Watch
Boehringer Ingelheim Auslandsbeteiligungs GmbH

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Premium Service
Unlock Dossier
What is a Dossier?
A dossier provides comprehensive company details as a PDF, together with all underlying original publications and original data in one place.
The download feature is exclusively available for our paid plan. Upgrade your account to access:
Quick Dossier
Entire company details as a PDF
Power Dossier
Entire company details along with all original publications / original data bundled in a ZIP file
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more
Learn more
View plans

Name

Boehringer Ingelheim Auslandsbeteiligungs GmbH

Identification

Ut
District Court of Mainz HRB 23112
PT
PT 980490111
Lei
529900ORCA4PGYL3WV90
EUID
DET2304V.HRB23112

Address

Binger Str. 173, 55218 Ingelheim a. Rhein, Germany

Corporate purpose

The object of the company is the acquisition and sale, holding and management of shareholdings. The Company may also operate in the pharmaceutical business, in particular by developing, manufacturing and distributing chemical or pharmaceutical products or commissioning others to do so.

Financial performance

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Network

Loading network

Legal Structure

Current legal representatives Legal form information · Proxy policies Premium
Premium
2Managing Director
12Authorized signatory (ppa)
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
tax haven banner
Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Shareholders and Investors
One known shareholder
Portfolio and Investments
5 known active shareholdings
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Base/share capital
Total assets
Earnings
Revenue
Revenue CAGR
Return on sales
Equity
Equity ratio
Return on equity
Employee number
Revenue per employee
Cash on hand
Receivables
Liabilities
Wages and salaries
Average salaries per employee
Pension provisions
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
Financial Statements Interactive sheets with CSV/Excel download Premium
Premium
Balance
from 2005 to 2024
Profit & Loss
from 2005 to 2024
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Publications

20 Feb 2026 via C.H. Boehringer Sohn AG & Co. KG also 02/05/2025, 02/10/2024, 08/04/2024, 21/12/2022, 22/12/2021, 15/12/2020, 08/01/2020, 13/12/2018, 03/01/2018, 12/01/2017, 25/02/2016, 17/04/2015, 14/05/2014, 14/02/2013, 16/12/2011, 21/12/2010, 22/12/2009, 19/02/2008
Shareholder: C.H. Boehringer Sohn AG & Co. KG
12 Jan 2026
Managing Director: Dana Leskova · No longer Managing Director: Frank Th. Hübler · Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (3)
12 Jan 2026 via Boehringer Ingelheim International GmbH also 05/02/2025, 16/02/2024, 13/03/2023, 12/01/2022, 13/01/2021, 13/02/2020, 23/01/2019, 01/02/2018, 09/01/2017, 02/12/2015, 08/12/2011, 10/01/2011
Shareholder: Boehringer Ingelheim International GmbH
8 Jan 2026
Annual report for the year ending 31/12/2024 · Balance sheet for 31/12/2024 · Earnings statement for 31/12/2024 · 3 Shareholdings: Anteile an Verbundenen Unternehmen, Sonstige Ausleihungen …
6 May 2025
Authorized signatory (ppa): Rene Weberskirch · No longer Authorized signatory (ppa): Mathieu Duchamp
4 Feb 2025
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023 · Earnings statement for 31/12/2023
12 Dec 2024
Authorized signatory (ppa): Kai Ruschkar · No longer Authorized signatory (ppa): Martin Mauer
19 Jun 2024
Managing Director: Martin Josef Schwarz · Authorized signatory (ppa): Mathieu Duchamp · No longer Managing Director: Michael Schmelmer · No longer Authorized signatory (ppa): Martin Josef Schwarz
7 Mar 2024
Authorized signatory (ppa): Sandrine Bianchi · No longer Authorized signatory (ppa) (1)
24 Jan 2024
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022
29 Mar 2023
Authorized signatory (ppa): Susanne Listl-Nörr
13 Feb 2023
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021
26 Oct 2022
No longer Authorized signatory (ppa) (2) · Authorized signatory (ppa) (1)
24 Jan 2022
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020
12 Jan 2022
Authorized signatory (ppa): Alexander Roh, Sven Sommerlatte
10 Aug 2021
Authorized signatory (ppa): Andrea Jakob · No longer Authorized signatory (ppa) (1)
12 Jan 2021
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019
11 Jan 2021
No longer Authorized signatory (ppa) (1)
4 Jan 2021 via Boehringer Ingelheim Portugal Lda. also 24/04/2013
Shareholding: Boehringer Ingelheim Portugal Lda
19 Dec 2019
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018
25 Oct 2019
Managing Director: Frank Hübler · No longer Managing Director: Andreas Neumann · No longer Authorized signatory (ppa): Frank Hübler
9 Apr 2019
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
14 Mar 2019
Authorized signatory (ppa) (2)
8 Jan 2019
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017
19 Apr 2018
Authorized signatory (ppa): Martin Mauer
2 Mar 2018
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016
1 Mar 2018 via Boehringer Ingelheim Animal Health Denmark A/S
Shareholding, No longer Voting rights: Boehringer Ingelheim Animal Health Denmark A/S
16 Jan 2018
Managing Director: Michael Schmelmer · Authorized signatory (ppa): Frank Hübler · No longer Managing Director (5) · No longer Authorized signatory (ppa) (3)
1 Jan 2018 via Boehringer Ingelheim Animal Health Denmark A/S
Shareholding, Voting rights: Merial Norden A/S
23 Jan 2017
Authorized signatory (ppa) (1)
14 Sept 2016
Managing Director: Simone Menne · Authorized signatory (ppa) (2)
6 Jul 2016
No longer Managing Director (2)
18 Jan 2016
Managing Director: Michel Pairet
26 Oct 2015
Managing Director: Andreas Neumann · No longer Authorized signatory (ppa) (3)
15 Oct 2015 via Dr.Karl Thomae GmbH also 23/03/2015
Shareholder: Dr.Karl Thomae GmbH
Year 2014 in Pas
2 Shareholdings: Boehringer Ingelheim, Lda., Unilfarma-União Internacional de Laboratórios Farmacêuticos Lda.
13 Nov 2014
Authorized signatory (ppa) (3)
17 Mar 2014 via Boehringer Ingelheim Verwaltungs GmbH also 07/12/2012
Shareholder: Boehringer Ingelheim Verwaltungs GmbH
25 Feb 2014
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012 · Earnings statement for 31/12/2012
16 Jul 2013
No longer Authorized signatory (ppa) (2) · Managing Director (1) · Authorized signatory (ppa) (1) · No longer Managing Director (1)
22 Jan 2013
Managing Director: Allan Hillgrove · No longer Authorized signatory (ppa) (2) · No longer Managing Director (1)
14 Jan 2013
Managing Director: Allan Hillgrove · No longer Authorized signatory (ppa) (2) · No longer Managing Director (1)
18 Dec 2012
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011
19 Oct 2012
Managing Director: Joachim Hasenmaier
20 Jun 2012
Authorized signatory (ppa): Andreas Neumann, Martin Schwarz
12 Jun 2012
Authorized signatory (ppa): Andreas Neumann, Martin Schwarz
30 Dec 2011
Capital: €25,100 · Share­holder agreement
28 Dec 2011
Original document: “Liste der Gesellschafter“
16 Dec 2011
Original document: “Liste der Gesellschafter“
16 Dec 2011
Original document: “Gesellschaftsvertrag / Satzung / Statut“
25 Nov 2011
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010 · Earnings statement for 31/12/2010
30 May 2011
Authorized signatory (ppa) (4) · No longer Authorized signatory (ppa) (4) · Profit Transfer: Boehringer Ingelheim International GmbH · Control: Boehringer Ingelheim International GmbH
6 May 2011
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
15 Dec 2010
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009 · Earnings statement for 31/12/2009 · 65 Shareholdings (65 companies)
26 Mar 2010
Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008 · Earnings statement for 31/12/2008 · 61 Shareholdings (61 companies)
19 Nov 2009
Registered ex officio in accordance with § 3 EGGmbHG: Business address: Binger Strasse 173, 55216 Ingelheim
22 Jan 2009
Managing Director (4) · No longer Authorized signatory (ppa) (3) · No longer Managing Director (2)
26 Nov 2008
Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007 · Earnings statement for 31/12/2007 · 39 Shareholdings (39 companies)
15 Aug 2008 via Boehringer Ingelheim Europe GmbH also 08/08/2008
Acquisition, Break-up: Boehringer Ingelheim Europe GmbH
15 Aug 2008
Acquisition: Boehringer Ingelheim Europe GmbH · Break-up: Boehringer Ingelheim Europe GmbH
4 Aug 2008
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
29 Feb 2008
Authorized signatory (ppa): Jochen Gann · No longer Authorized signatory (ppa) (3)
11 Feb 2008
Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006 · Earnings statement for 31/12/2006 · 66 Shareholdings (66 companies)
15 Dec 2006
Authorized signatory (ppa) (1)
4 Dec 2006
Authorized signatory (ppa) (1)
8 Dec 2005
Reg­is­tra­tion · ppa (14) · MD (2) · Merger: PI Beteiligungs GmbH · Capital: €25,000 · Seat: Ingelheim · Legal form: GmbH · Name: Boehringer Ingelheim Auslandsbeteiligungs GmbH · Corporate Purpose
14 Aug 1990 via Boehringer Ingelheim Danmark A/S
Shareholding, Voting rights: A/S PSE NR. 3967
There are no publications matching your search.

Mentions

19 Aug 2026 in Ler
Direct parent
19 Aug 2026 in Ler
Ultimate parent
20 Jul 2026 in Ktreg
Shareholding: Boehringer Ingelheim (Schweiz) GmbH
25 Mar 2024 in Vr
Shareholding: Boehringer Ingelheim s.r.o
17 Dec 2018 in Ler
No longer Direct parent: Boehringer Ingelheim España SA
17 Dec 2018 in Ler
No longer Direct parent: Boehringer Ingelheim Ltd
25 Sept 2018 in Ler
No longer Direct parent: Monoprosopi Anonymos Etaireia Paragogis Chimikon kai Farmakeftikon Proionton Boehringer Ingelheim Ellas MAE A.E
10 Nov 2015 in Hrdk also 09/10/2015
Boehringer Ingelheim Invest GmbH: “Liste der Gesellschafter“
via Firmenbuch in Bmjfbv
LP: Boehringer Ingelheim RCV GmbH & Co. KG · Shareholding: Boehringer Ingelheim Pharma GmbH · No longer LP: Boehringer Ingelheim RCV GmbH & Co. KG · Shareholding: Boehringer Ingelheim Pharma GmbH
via WZ in Wzfma
2 Shareholdings: Boehringer Ingelheim Austria GmbH, Boehringer Ingelheim Pharma GmbH · Shareholding: Boehringer Ingelheim Pharma GmbH
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.